Development and validation of a deep learning-based model to predict response and survival of T790M mutant non-small cell lung cancer patients in early clinical phase trials using electronic medical record and pharmacokinetic data.

Fujovee (abivertinib) - Sorrento

rezivertinib (BPI-7711) - Beta Pharma

http://www.ncbi.nlm.nih.gov/pubmed/38736496

Chi Xu; Ji Jiang; Lu Wang; Nan Qiao; Ning Lou; Ruyun Gao; Shanbo Wang; Wei Shen; Weicong Wang; Xiaohong Han; Xin Zheng; Xinge Cui; Xinyuan Lin

May 13, 2024